Blog Category

Thoughts Leading Up To #BIO2017 
Posted on Jun 15, 2017

  #BIO2017 is days away. What can we expect?   Crowded Partnering – By our unofficial count, the number of companies registered for One-on-One Partnering exceeds the number from San Francisco last year. While having more Exhibitors is nice, more people and companies in Partnering means more opportunities to in- or out-license, find new clients,

What is your Acceptance Rate? 
Posted on Jun 02, 2017

  An Acceptance Rate is simply the percentage of meeting requests which are accepted at a given conference. At Lacerta Bio, we have been tracking Acceptance Rates for conferences since 2011. We track it for every conference at the corporate level, and also at the client level. But why bother? Daily Planning – Using historical

NSAIDs: More Bad News 
Posted on May 15, 2017

  NSAIDs are an $11-12+ billion market, yet the problems with these drugs continue to make headlines.  The most recent study examined data from nearly 450,000 patients, and concluded (our emphasis):  All NSAIDs, including naproxen, were found to be associated with an increased risk of acute myocardial infarction. Risk of myocardial infarction with celecoxib was

Google Plus   Facebook   Twitter
Powered By : Supra International Inc.